Burdash N M, Hinds K K, Finnerty J A, Manos J P
J Clin Microbiol. 1987 May;25(5):808-11. doi: 10.1128/jcm.25.5.808-811.1987.
An enzyme-linked immunosorbent assay for Treponema pallidum antibody (Syphilis Bio-EnzaBead Kit; Organon Teknika Corp., formerly Litton Bionetics, Kensington, Md.) was compared with the standard fluorescent treponemal antibody absorption test for syphilis (indirect fluorescent-antibody confirmatory test; Zeus Scientific Inc., Raritan, N.J.). Six hundred specimens tested in the rapid plasma Reagin card test (Hynson, Westcott and Dunning, Inc., Baltimore, Md.) and microhemagglutination assay for antibodies to T. pallidum (Ames Division, Miles Laboratories, Inc., Elkhart, Ind.) were used for comparison testing. One hundred and sixty-two specimens were from either persons with syphilis or persons whose history was unknown but who showed reactive serology, whereas 438 were from persons without syphilis. The reactivity of each serum by the Bio-EnzaBead test was determined visually and from optical density readings. Excellent reproducibility of visual readings was obtained; all results were within +/- 1 gradation of the expected readings in all 60 coded sera tested. Overall agreement between the Bio-EnzaBead and fluorescent treponemal antibody absorption test results was 96.3% when read visually and greater than or equal to 95.7% when using optical density readings. Our data indicate that Bio-EnzaBead results read at 405 nm and determined by using the mean antigen optical density reading of the nonreactive control plus 0.025 as the cutoff value provide an overall sensitivity and specificity of 93.0 and 98.6%, respectively, along with the best agreement with the fluorescent treponemal antibody absorption assay. Ease of performance and objectivity also contribute toward the acceptability of this assay as an alternative confirmatory test for syphilis.
对梅毒螺旋体抗体的酶联免疫吸附测定(梅毒生物酶珠试剂盒;奥加农泰尼克公司,前身为利顿生物遗传学公司,马里兰州肯辛顿)与梅毒标准荧光密螺旋体抗体吸收试验(间接荧光抗体确证试验;宙斯科学公司,新泽西州拉里坦)进行了比较。在快速血浆反应素卡片试验(海森、韦斯科特和邓宁公司,马里兰州巴尔的摩)和梅毒螺旋体抗体微量血凝试验(迈尔斯实验室公司艾姆斯分部,印第安纳州埃尔克哈特)中检测的600份标本用于比较测试。162份标本来自梅毒患者或病史不明但血清学反应呈阳性的人,而438份标本来自无梅毒的人。通过生物酶珠试验对每份血清的反应性通过目视和光密度读数来确定。目视读数具有出色的重现性;在所有测试的60份编码血清中,所有结果均在预期读数的+/-1个等级范围内。生物酶珠试验和荧光密螺旋体抗体吸收试验结果之间的总体一致性,目视读数时为96.3%,使用光密度读数时大于或等于95.7%。我们的数据表明,在405nm处读取的生物酶珠试验结果,以非反应性对照的平均抗原光密度读数加0.025作为临界值,总体敏感性和特异性分别为93.0%和98.6%,并且与荧光密螺旋体抗体吸收试验的一致性最佳。操作简便性和客观性也有助于使该试验作为梅毒的替代确证试验被接受。